William A. Haseltine, Contributor

Author's posts

FDA Authorizes New Antibody Treatment For Severe Covid-19

A new monoclonal antibody is now available for the treatment of severe Covid after a recent FDA emergency use authorization.

NANOG (Part 1): Its Role In Aging And Cancer

Recent research suggests that NANOG protein may play a crucial role in aging and cancer development. Here, I provide a brief overview of the NANOG protein.

Promising Monoclonal Antibodies For The Treatment Of Yellow Fever Virus

New monoclonal antibodies may provide treatment for Yellow Fever virus patients; a disease that currently lacks any viable treatments.

Virusoids: Viruses’ Very Own Parasites

Virusoids are strands of circular RNA that infect hosts by hitching rides on viruses. Once inside, they can replicate and spread undisturbed.

Direct Acting Antiviral Drugs For The Treatment Of Hepatitis C

Recent progress in the development of several highly active, anti-hepatitis C drugs has been a triumph of modern medicine. These drugs usher in an era of effective treatment and even elimination of hepatitis C both nationally and globally.

Anti-ACE2 Monoclonal Antibodies To Prevent And Treat COVID-19

Anti-ACE2 antibodies may provide a new path for Covid-19 treatment in the wake of viral variants.

Opening The Door To The Use Of Antibodies To Protect Plants From Pathogens

New technologies are currently being explored to protect our agriculturally important plants from invading pathogens.

Cell Therapy Prevents Risk Of Heart Attack or Stroke: Study

A recent study searches for a permanent solution to repair the heart via stem cell therapy.

Progress Toward Effective Monoclonal Antibodies Treatments Against Covid-19 And Other Coronavirus Diseases

New advances in S2 antibodies may pave the way for more broadly effective monoclonal antibody treatments in the future.

Altered CAR T Therapy Shrinks Ovarian Tumors In Mice

CAR T cells with upgraded cell signaling shrink ovarian cancer tumors in mice better than standard CAR T cells, according to recent study results.